Status:
COMPLETED
EXPLorative Data Collection for Patient chAracterIzation, treatmeNt Pathways and Outcomes of IRON Preparations
Lead Sponsor:
GWT-TUD GmbH
Collaborating Sponsors:
Shield Therapeutics
Conditions:
Iron-deficiency
Eligibility:
All Genders
18-99 years
Brief Summary
By describing the characteristics of iron deficiency (ID) patients treated with various oral or intravenous iron formulations and their outcomes, this registry will provide the medical community with ...
Detailed Description
Iron deficiency (ID) anaemia is a prevalent condition in Germany and other Western countries. It is a common complication in inflammatory bowel disease (IBD), cardiovascular disease including chronic ...
Eligibility Criteria
Inclusion
- Female or male patients, aged at least 18 years
- Clinical diagnosis of iron deficiency according to treating physician
- Decision to treat with an oral or intravenous iron supplementation made by treating physician considering the indications of the respective Summary of Product Characteristics (prescribing information)
- maintenance or newly initiated treatment (including returning quitters)
- written informed consent
Exclusion
- patient not available for long-term documentation
- concomitant or planned participation in a clinical trial (on iron supplementation)
- concomitant over-the-counter iron supplementation
Key Trial Info
Start Date :
January 16 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 20 2019
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT03382275
Start Date
January 16 2018
End Date
April 20 2019
Last Update
July 2 2019
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Praxis für Gastroenterologie
Berlin, Germany, 10318
2
Klinik für Innere Medizin I des Universiätsklinikums
Kiel, Germany, 24105